[{"path":"index.html","id":"about","chapter":"About","heading":"About","text":"Information presented intended help preparation Clinical Hematology content areas described ASCP BOC’s Content Guidelines MLS, H, SH certification exams.recommend use information supplement “Reading List” cited ASCP BOC certification.Tools used creation book:experience Clinical HematologyR, RStudio, Bookdown R packageOpenAI’s ChatGPT","code":""},{"path":"index.html","id":"author","chapter":"About","heading":"Author","text":"graduated Augusta University’s Clinical Laboratory Science program 2013. worked Clinical Hematology bench Augusta University Medical Center full time 2013-18. 2016, earned Specialist Hematology (ASCP). working, gained experience Bone Marrow Flow Cytometry bench successful Specialist Cytometry (ASCP) 2018.Since September 2018, teaching full time Augusta University’s Clinical Laboratory Science program primary teaching focus Clinical Hematology. still practice Clinical Hematology, Bone Marrow, Flow Cytometry Laboratory one day week.","code":""},{"path":"a.-production.html","id":"a.-production","chapter":"A. Production","heading":"A. Production","text":"Production cellular elements - erythocytes, leukocytes, platelets","code":""},{"path":"a.-production.html","id":"hematopoiesis","chapter":"A. Production","heading":"1.1 Hematopoiesis","text":"Hematopoiesis process new blood cells formed body. Hematopoiesis primarily occurs bone marrow, soft, spongy tissue found inside cavities bones. Hematopoiesis crucial maintaining constant supply blood cells, including erythrocytes (red blood cells, RBCs), leukocytes (white blood cells, WBCs), thrombocytes (platelets, PLTs).following terms used discussing hematopoiesis single cell line:Erythropoiesis: process red blood cell productionLeukopoiesis: process white blood cell productionThrombopoiesis: process platelet production","code":""},{"path":"a.-production.html","id":"locations","chapter":"A. Production","heading":"1.1.1 Locations","text":"Locations hematopoiesis differ gestation (period development womb) compared birth.gestation, hematopoiesis occurs different locations fetus matures. following breakdown specific locations hematopoiesis gestation. important note gradual transition activity hematopoiesis following stages/organs.Month 1, Yolk Sac: early stages embryonic development, hematopoiesis first occurs yolk sac. yolk sac extraembryonic membrane provides nourishment developing embryo. serves primary site hematopoiesis first weeks gestation.Primitive erythrocytes majority cell produced. cells help supply oxygen developing embryo organs take role erythropoiesis. Leukopoiesis thrombopoiesis less active.Months 1 - 3, Liver: fetus develops, hematopoiesis shifts liver, typically around sixth week gestation. liver becomes major site hematopoiesis mid-gestation. Hepatic hematopoiesis plays crucial role producing red blood cells, white blood cells, platelets.Erythropoiesis continues produces erythrocytes advanced development compared formed yolk sac. Likewise leukopoiesis thrombopoeisis. Leukopoeisis produces various types white blood cells, including granulocytes (neutrophils, eosinophils, basophils), monocytes, lymphocytes. Thrombopoiesis produces larger, mature megakaryocytes, responsible generating platelets.Months 3 - 9, Spleen: Around ninth week gestation, spleen becomes secondary site hematopoiesis. contributes production red blood cells lymphocytes. spleen’s involvement hematopoiesis decreases bone marrow takes function later gestation. fetus approaches full-term, bone marrow becomes primary site hematopoiesis, taking liver spleen.Erythropoiesis, leukopoiesis, thrombopoiesis fully transition cycle producing mature RBCs, WBCs, PLTs, respectively.Overall, gestation, erythropoiesis, leukopoiesis, thrombopoiesis starts yolk sac, progresses liver, progresses spleen, finally settles bone marrow. transition reflects development maturation hematopoietic system fetus.birth, hematopoiesis activity fully transitions bone marrow, termed medullary hematopoiesis. certain conditions diseases hematopoiesis can occur outside bone marrow, liver spleen, termed extramedullary hematopoiesis.Medullary hematopoiesis primary production erythrocytes, leukocytes, thrombocytes health individuals. process tightly regulated various growth factors, cytokines, hormones, ensuring balance production different blood cell types needed body. Locations highest hematopoietic activity bone cavities axial skeleton, pelvis, proximal ends long bones.Extramedullary hematopoiesis generally considered abnormal process triggered pathological conditions, chronic anemia, myelofibrosis, bone marrow disorders. often compensatory mechanism triggered bone marrow’s capacity produce blood cells compromised increased demand blood cell production.","code":""},{"path":"a.-production.html","id":"marrow-composition","chapter":"A. Production","heading":"1.1.2 Marrow Composition","text":"Red marrow yellow marrow two types bone marrow found within cavities bones.Red marrow consists highly cellular vascularized tissue matrix. contains mix hematopoietic cells, adipocytes (fat cells), blood vessels, supportive stromal cells. Red marrow active site hematopoiesis, blood cells produced. harbors hematopoietic stem cells (HSCs) capacity differentiate various blood cell lineages, including erythrocytes, leukocytes, thrombocytes. Red marrow soft, spongy texture appears reddish color due rich blood supply presence numerous hematopoietic cells. adults, red marrow predominantly found axial skeleton (skull, vertebral column, ribs, sternum), pelvis, proximal ends long bones (femur humerus). Red marrow plays vital role maintaining constant production blood cells throughout life. provides supportive microenvironment essential growth factors proliferation, differentiation, maturation blood cell precursors.Stromal Cells diverse group non-hematopoietic cells provide structural support contribute microenvironment various tissues organs, including bone marrow. cells play critical roles regulating hematopoiesis, immune function, tissue repair, overall tissue homeostasis. bone marrow, stromal cells include:Stromal Cell Types:Osteoblasts: cells responsible bone formation help maintain structural integrity bone marrow.Endothelial Cells: Endothelial cells form inner lining blood vessels contribute angiogenesis, formation new blood vessels.Fibroblasts: Fibroblasts produce extracellular matrix (ECM) components, including collagen structural proteins, providing support organization bone marrow.Adipocytes: Adipocytes fat cells found yellow marrow contribute energy storage.Mesenchymal Stem/Stromal Cells (MSCs): MSCs multipotent cells can differentiate various cell types, including osteoblasts, adipocytes, fibroblasts. also immunomodulatory properties can support hematopoiesis.Stromal Cells’ Functions Roles:Structural Support: Stromal cells help maintain structural architecture organization tissues, including bone marrow, creating supportive framework cells.Niche Regulation: Stromal cells create specialized microenvironments, known niches, regulate behavior function hematopoietic stem cells (HSCs) cells within bone marrow. secrete various factors cytokines influence HSC self-renewal, differentiation, migration.Cell-Cell Interactions: Stromal cells engage intricate interactions hematopoietic cells, immune cells, neighboring cells direct contact paracrine signaling. interactions influence development, differentiation, function various cell types within bone marrow.Immune Modulation: Stromal cells within bone marrow contribute immune regulation response. can modulate activity immune cells, regulate inflammation, influence balance immune tolerance immune response.Extracellular Matrix (ECM) Production: Stromal cells synthesize maintain ECM components, provide physical support, regulate cell adhesion, play role cell signaling tissue organization.Hematopoietic Support: Stromal cells, particularly MSCs, provide crucial support hematopoiesis. secrete factors cytokines (e.g., stem cell factor, interleukin-7) provide physical contact adhesion molecules regulate survival, proliferation, differentiation hematopoietic cells.summary, stromal cells bone marrow contribute microenvironment support functions hematopoietic cells. provide structural support, regulate niche signaling, produce extracellular matrix components, engage cell-cell interactions, play roles immune modulation hematopoietic support.Yellow marrow mainly composed adipocytes (fat cells) reduction vascularity, give yellowish appearance. higher proportion fat cells compared red marrow. Yellow marrow minimal hematopoietic activity, meaning produces significantly lower number blood cells compared red marrow. contains fewer hematopoietic cells less active microenvironment blood cell production. Yellow marrow present central cavities long bones, femur humerus, well medullary cavity bones. Yellow marrow serves energy reserve contributes overall fat metabolism body. provides insulation cushioning within bone cavities. certain circumstances, increased demand blood cell production response certain pathological conditions, yellow marrow can convert back red marrow. known reconversion reactivation hematopoiesis.Ratio Red Marrow Yellow Marrow ’s important note red marrow primary site hematopoiesis healthy adults, distribution ratio red yellow marrow can vary among individuals throughout different stages life. age, red marrow undergoes physiological transformation yellow marrow, reducing hematopoietic activity becoming progressively replaced adipose (fat) cells. rough guide evaluate normal concentrations red marrow yellow marrow use individual’s age (+/- 10%) concentration yellow marrow. residual red marrow. examples:Healthy 10-year old 80% - 100% red marrow 0% - 20% yellow marrowHealthy 70-year old 60% - 80% yellow marrow 20% - 40% red marrow","code":""},{"path":"a.-production.html","id":"cell-development","chapter":"A. Production","heading":"1.1.3 Cell Development","text":"process hematopoiesis involves differentiation maturation hematopoietic stem cells (HSCs). HSCs multipotent cells ability give rise types blood cells (ie RBCs, WBCs, PLTs). reside bone marrow undergo series steps produce fully mature blood cells.stages involved hematopoiesis:Pluripotent Stem Cells: Hematopoiesis begins pluripotent stem cells, undifferentiated cells capable differentiating various cell types, including self-replication. cells give rise myeloid lymphoid lineages.Pluripotent Stem Cells: Hematopoiesis begins pluripotent stem cells, undifferentiated cells capable differentiating various cell types, including self-replication. cells give rise myeloid lymphoid lineages.Commitment Differentiation: Pluripotent stem cells differentiate multipotent progenitor (MPP) cells. progenitor cells committed either myeloid lymphoid lineage.\nMyeloid Lineage: myeloid lineage, MPPs differentiate common myeloid progenitor (CMP) cells. CMPs give rise specific progenitor cells various blood cell types, erythrocyte progenitor cells (develop RBCs), granulocyte/monocyte progenitor cells (develop WBCs), megakaryocyte progenitor cells (develop PLTs).\nLymphoid Lineage: lymphoid lineage, MPPs differentiate common lymphoid progenitor (CLP) cells. CLPs give rise progenitor cells lymphocytes, including B cells, T cells, natural killer (NK) cells.\nCommitment Differentiation: Pluripotent stem cells differentiate multipotent progenitor (MPP) cells. progenitor cells committed either myeloid lymphoid lineage.Myeloid Lineage: myeloid lineage, MPPs differentiate common myeloid progenitor (CMP) cells. CMPs give rise specific progenitor cells various blood cell types, erythrocyte progenitor cells (develop RBCs), granulocyte/monocyte progenitor cells (develop WBCs), megakaryocyte progenitor cells (develop PLTs).Lymphoid Lineage: lymphoid lineage, MPPs differentiate common lymphoid progenitor (CLP) cells. CLPs give rise progenitor cells lymphocytes, including B cells, T cells, natural killer (NK) cells.process hematopoiesis tightly regulated various growth factors, cytokines, hormones. example, erythropoietin (EPO) stimulates production erythrocytes, granulocyte colony-stimulating factor (G-CSF) promotes development granulocytes.","code":""},{"path":"a.-production.html","id":"conclusion","chapter":"A. Production","heading":"1.2 Conclusion","text":"Hematopoiesis dynamic continuous process ensures replenishment blood cells throughout individual’s life. crucial maintaining healthy immune system proper functioning oxygen transport (via RBCs), blood clotting (via PLTs), defense infections (via WBCs).","code":""},{"path":"b.-destruction.html","id":"b.-destruction","chapter":"B. Destruction","heading":"B. Destruction","text":"RES","code":""},{"path":"c.-function.html","id":"c.-function","chapter":"C. Function","heading":"C. Function","text":"Normal cellular functions","code":""},{"path":"c.-function.html","id":"erythrocytes","chapter":"C. Function","heading":"1.3 Erythrocytes","text":"production erythrocytes, also known red blood cells, occurs process called erythropoiesis. takes place bone marrow, specifically “spongy” bone. Erythropoiesis regulated hormone erythropoietin (EPO), produced primarily kidneys response low oxygen levels body.process erythropoiesis can divided several stages:Hematopoietic Stem Cell (HSC) Differentiation: Hematopoietic stem cells, multipotent cells found bone marrow, give rise blood cell types. influence various growth factors cytokines, small population HSCs differentiate specialized type stem cell called burst-forming unit-erythroid (BFU-E) cell.Hematopoietic Stem Cell (HSC) Differentiation: Hematopoietic stem cells, multipotent cells found bone marrow, give rise blood cell types. influence various growth factors cytokines, small population HSCs differentiate specialized type stem cell called burst-forming unit-erythroid (BFU-E) cell.Proerythroblast Stage: BFU-E cells differentiate proerythroblasts, committed becoming erythrocytes. Proerythroblasts large cells prominent nucleus characterized intense basophilic staining due presence ribosomes.Proerythroblast Stage: BFU-E cells differentiate proerythroblasts, committed becoming erythrocytes. Proerythroblasts large cells prominent nucleus characterized intense basophilic staining due presence ribosomes.Erythroblast Stage: Proerythroblasts undergo several divisions form series erythroblasts. divisions, cells gradually decrease size nucleus becomes smaller denser. stages erythroblasts include basophilic erythroblast, polychromatic erythroblast, orthochromatic erythroblast.Erythroblast Stage: Proerythroblasts undergo several divisions form series erythroblasts. divisions, cells gradually decrease size nucleus becomes smaller denser. stages erythroblasts include basophilic erythroblast, polychromatic erythroblast, orthochromatic erythroblast.Reticulocyte Formation: Orthochromatic erythroblasts develop reticulocytes. stage, nucleus extruded cell, remaining cytoplasm becomes densely packed hemoglobin. Reticulocytes contain residual ribosomal RNA, gives reticular mesh-like appearance stained certain dyes. still capable protein synthesis lack nucleus.Reticulocyte Formation: Orthochromatic erythroblasts develop reticulocytes. stage, nucleus extruded cell, remaining cytoplasm becomes densely packed hemoglobin. Reticulocytes contain residual ribosomal RNA, gives reticular mesh-like appearance stained certain dyes. still capable protein synthesis lack nucleus.Maturation Release: Reticulocytes released bone marrow bloodstream, continue mature mature erythrocytes red blood cells. process, reticular material removed cell, becomes fully mature erythrocyte. entire maturation process proerythroblast stage release reticulocytes takes around 7-8 days.Maturation Release: Reticulocytes released bone marrow bloodstream, continue mature mature erythrocytes red blood cells. process, reticular material removed cell, becomes fully mature erythrocyte. entire maturation process proerythroblast stage release reticulocytes takes around 7-8 days.Throughout erythropoiesis, production maturation erythrocytes tightly regulated various factors, EPO, iron availability, vitamin B12, folic acid. factors essential synthesis hemoglobin, oxygen-carrying protein found erythrocytes. released bloodstream, mature erythrocytes circulate 120 days, removed spleen liver, new erythrocytes continually produced maintain stable red blood cell count body.","code":""},{"path":"c.-function.html","id":"leukoctyes","chapter":"C. Function","heading":"1.4 Leukoctyes","text":"","code":""},{"path":"c.-function.html","id":"thrombocytes","chapter":"C. Function","heading":"1.5 Thrombocytes","text":"","code":""},{"path":"a.-erythrocytes.html","id":"a.-erythrocytes","chapter":"A. Erythrocytes","heading":"A. Erythrocytes","text":"","code":""},{"path":"a.-erythrocytes.html","id":"anemia","chapter":"A. Erythrocytes","heading":"2.1 Anemia","text":"","code":""},{"path":"a.-erythrocytes.html","id":"microcytic","chapter":"A. Erythrocytes","heading":"2.1.1 Microcytic","text":"","code":""},{"path":"a.-erythrocytes.html","id":"iron-deficiency","chapter":"A. Erythrocytes","heading":"2.1.1.1 Iron Deficiency","text":"","code":""},{"path":"a.-erythrocytes.html","id":"thalassemia","chapter":"A. Erythrocytes","heading":"2.1.1.2 Thalassemia","text":"","code":""},{"path":"a.-erythrocytes.html","id":"sideroblastic","chapter":"A. Erythrocytes","heading":"2.1.1.3 Sideroblastic","text":"","code":""},{"path":"a.-erythrocytes.html","id":"chronic-inflammation","chapter":"A. Erythrocytes","heading":"2.1.1.4 Chronic Inflammation","text":"","code":""},{"path":"a.-erythrocytes.html","id":"normocytic","chapter":"A. Erythrocytes","heading":"2.1.2 Normocytic","text":"","code":""},{"path":"a.-erythrocytes.html","id":"hereditary-hemolytic","chapter":"A. Erythrocytes","heading":"2.1.2.1 Hereditary Hemolytic","text":"","code":""},{"path":"a.-erythrocytes.html","id":"acquired-hemolytic","chapter":"A. Erythrocytes","heading":"2.1.2.2 Acquired Hemolytic","text":"","code":""},{"path":"a.-erythrocytes.html","id":"hypoproliferative","chapter":"A. Erythrocytes","heading":"2.1.2.3 Hypoproliferative","text":"","code":""},{"path":"a.-erythrocytes.html","id":"acute-hemorrhage","chapter":"A. Erythrocytes","heading":"2.1.2.4 Acute Hemorrhage","text":"","code":""},{"path":"a.-erythrocytes.html","id":"macrocytic","chapter":"A. Erythrocytes","heading":"2.1.3 Macrocytic","text":"","code":""},{"path":"a.-erythrocytes.html","id":"megaloblastic","chapter":"A. Erythrocytes","heading":"2.1.3.1 Megaloblastic","text":"","code":""},{"path":"a.-erythrocytes.html","id":"non-megaloblastic","chapter":"A. Erythrocytes","heading":"2.1.3.2 Non-Megaloblastic","text":"","code":""},{"path":"a.-erythrocytes.html","id":"hemoglobinopathies","chapter":"A. Erythrocytes","heading":"2.1.4 Hemoglobinopathies","text":"","code":""},{"path":"a.-erythrocytes.html","id":"erythrocytosis","chapter":"A. Erythrocytes","heading":"2.2 Erythrocytosis","text":"","code":""},{"path":"a.-erythrocytes.html","id":"realtive","chapter":"A. Erythrocytes","heading":"2.2.1 Realtive","text":"","code":""},{"path":"a.-erythrocytes.html","id":"absolute","chapter":"A. Erythrocytes","heading":"2.2.2 Absolute","text":"","code":""},{"path":"b.-leukocytes.html","id":"b.-leukocytes","chapter":"B. Leukocytes","heading":"B. Leukocytes","text":"","code":""},{"path":"b.-leukocytes.html","id":"benign-leukocyte-disorders","chapter":"B. Leukocytes","heading":"2.3 Benign Leukocyte Disorders","text":"","code":""},{"path":"b.-leukocytes.html","id":"myeloid","chapter":"B. Leukocytes","heading":"2.3.1 Myeloid","text":"","code":""},{"path":"b.-leukocytes.html","id":"lymphoid","chapter":"B. Leukocytes","heading":"2.3.2 Lymphoid","text":"","code":""},{"path":"b.-leukocytes.html","id":"myeloid-neoplasia","chapter":"B. Leukocytes","heading":"2.4 Myeloid Neoplasia","text":"","code":""},{"path":"b.-leukocytes.html","id":"acute-leukemia","chapter":"B. Leukocytes","heading":"2.4.1 Acute Leukemia","text":"","code":""},{"path":"b.-leukocytes.html","id":"myelodysplastic-syndromes","chapter":"B. Leukocytes","heading":"2.4.2 Myelodysplastic Syndromes","text":"","code":""},{"path":"b.-leukocytes.html","id":"myeloproliferative-neoplasms","chapter":"B. Leukocytes","heading":"2.4.3 Myeloproliferative Neoplasms","text":"","code":""},{"path":"b.-leukocytes.html","id":"lymphoid-neoplasia","chapter":"B. Leukocytes","heading":"2.5 Lymphoid Neoplasia","text":"","code":""},{"path":"b.-leukocytes.html","id":"acute-leukemia-1","chapter":"B. Leukocytes","heading":"2.5.1 Acute Leukemia","text":"","code":""},{"path":"b.-leukocytes.html","id":"chronic-leukemialymphoma","chapter":"B. Leukocytes","heading":"2.5.2 Chronic Leukemia/Lymphoma","text":"","code":""},{"path":"b.-leukocytes.html","id":"plasma-cell-dyscrasias","chapter":"B. Leukocytes","heading":"2.5.3 Plasma Cell Dyscrasias","text":"","code":""},{"path":"b.-leukocytes.html","id":"hereditary-anomalies","chapter":"B. Leukocytes","heading":"2.6 Hereditary Anomalies","text":"","code":""},{"path":"c.-thrombocytes.html","id":"c.-thrombocytes","chapter":"C. Thrombocytes","heading":"C. Thrombocytes","text":"","code":""},{"path":"c.-thrombocytes.html","id":"quantitative-abnormalities","chapter":"C. Thrombocytes","heading":"2.7 Quantitative Abnormalities","text":"","code":""},{"path":"c.-thrombocytes.html","id":"thrombocytopenia","chapter":"C. Thrombocytes","heading":"2.7.1 Thrombocytopenia","text":"","code":""},{"path":"c.-thrombocytes.html","id":"increased-destruction","chapter":"C. Thrombocytes","heading":"2.7.1.1 Increased Destruction","text":"","code":""},{"path":"c.-thrombocytes.html","id":"decreased-production","chapter":"C. Thrombocytes","heading":"2.7.1.2 Decreased Production","text":"","code":""},{"path":"c.-thrombocytes.html","id":"pseudothrombocytopenia","chapter":"C. Thrombocytes","heading":"2.7.1.3 Pseudothrombocytopenia","text":"","code":""},{"path":"c.-thrombocytes.html","id":"thrombocytosis","chapter":"C. Thrombocytes","heading":"2.7.2 Thrombocytosis","text":"","code":""},{"path":"c.-thrombocytes.html","id":"qualitative-defects","chapter":"C. Thrombocytes","heading":"2.8 Qualitative Defects","text":"","code":""},{"path":"c.-thrombocytes.html","id":"von-willebrand-desease","chapter":"C. Thrombocytes","heading":"2.8.1 von Willebrand Desease","text":"","code":""},{"path":"c.-thrombocytes.html","id":"bernard-soulier-syndrome","chapter":"C. Thrombocytes","heading":"2.8.2 Bernard-Soulier Syndrome","text":"","code":""},{"path":"c.-thrombocytes.html","id":"glanzmann-thrombasthenia","chapter":"C. Thrombocytes","heading":"2.8.3 Glanzmann Thrombasthenia","text":"","code":""},{"path":"a.-cell-counts.html","id":"a.-cell-counts","chapter":"A. Cell Counts","heading":"A. Cell Counts","text":"","code":""},{"path":"a.-cell-counts.html","id":"manual","chapter":"A. Cell Counts","heading":"3.1 Manual","text":"","code":""},{"path":"a.-cell-counts.html","id":"automated","chapter":"A. Cell Counts","heading":"3.2 Automated","text":"","code":""},{"path":"a.-cell-counts.html","id":"reticulocyte","chapter":"A. Cell Counts","heading":"3.3 Reticulocyte","text":"","code":""},{"path":"b.-differentials-and-morphological-evaluation.html","id":"b.-differentials-and-morphological-evaluation","chapter":"B. Differentials and Morphological Evaluation","heading":"B. Differentials and Morphological Evaluation","text":"","code":""},{"path":"c.-hemoglobin.html","id":"c.-hemoglobin","chapter":"C. Hemoglobin","heading":"C. Hemoglobin","text":"","code":""},{"path":"c.-hemoglobin.html","id":"quantitative","chapter":"C. Hemoglobin","heading":"3.4 Quantitative","text":"","code":""},{"path":"c.-hemoglobin.html","id":"qualitative","chapter":"C. Hemoglobin","heading":"3.5 Qualitative","text":"","code":""},{"path":"c.-hemoglobin.html","id":"electrophoresis","chapter":"C. Hemoglobin","heading":"3.5.1 Electrophoresis","text":"","code":""},{"path":"c.-hemoglobin.html","id":"hplc","chapter":"C. Hemoglobin","heading":"3.5.2 HPLC","text":"","code":""},{"path":"c.-hemoglobin.html","id":"sickle-solubility","chapter":"C. Hemoglobin","heading":"3.5.3 Sickle Solubility","text":"","code":""},{"path":"d.-hematocrit.html","id":"d.-hematocrit","chapter":"D. Hematocrit","heading":"D. Hematocrit","text":"","code":""},{"path":"d.-indices.html","id":"d.-indices","chapter":"D. Indices","heading":"D. Indices","text":"","code":""},{"path":"e.-hemolytic-indicators.html","id":"e.-hemolytic-indicators","chapter":"E. Hemolytic Indicators","heading":"E. Hemolytic Indicators","text":"","code":""},{"path":"f.-special-stains.html","id":"f.-special-stains","chapter":"F. Special Stains","heading":"F. Special Stains","text":"","code":""},{"path":"f.-special-stains.html","id":"esterase","chapter":"F. Special Stains","heading":"3.6 Esterase","text":"","code":""},{"path":"f.-special-stains.html","id":"myeloperoxidase","chapter":"F. Special Stains","heading":"3.7 Myeloperoxidase","text":"","code":""},{"path":"f.-special-stains.html","id":"prussian-blue","chapter":"F. Special Stains","heading":"3.8 Prussian Blue","text":"","code":""},{"path":"f.-special-stains.html","id":"kleihauer-betke","chapter":"F. Special Stains","heading":"3.9 Kleihauer Betke","text":"","code":""},{"path":"h.-other-studies.html","id":"h.-other-studies","chapter":"H. Other Studies","heading":"H. Other Studies","text":"","code":""},{"path":"i.-flow-cytometry.html","id":"i.-flow-cytometry","chapter":"I. Flow Cytometry","heading":"I. Flow Cytometry","text":"","code":""},{"path":"i.-flow-cytometry.html","id":"leukemia","chapter":"I. Flow Cytometry","heading":"3.10 Leukemia","text":"","code":""},{"path":"i.-flow-cytometry.html","id":"lymphoma","chapter":"I. Flow Cytometry","heading":"3.11 Lymphoma","text":"","code":""},{"path":"i.-flow-cytometry.html","id":"lymphocyte-subsets","chapter":"I. Flow Cytometry","heading":"3.12 Lymphocyte Subsets","text":"","code":""},{"path":"i.-flow-cytometry.html","id":"pnh","chapter":"I. Flow Cytometry","heading":"3.13 PNH","text":"","code":""},{"path":"j.-molecular-and-cytogenetic.html","id":"j.-molecular-and-cytogenetic","chapter":"J. Molecular and Cytogenetic","heading":"J. Molecular and Cytogenetic","text":"","code":""},{"path":"j.-molecular-and-cytogenetic.html","id":"recurring-cytogenetic-abnormalities","chapter":"J. Molecular and Cytogenetic","heading":"3.14 Recurring Cytogenetic Abnormalities","text":"","code":""},{"path":"j.-molecular-and-cytogenetic.html","id":"bcrabl","chapter":"J. Molecular and Cytogenetic","heading":"3.15 BCR/ABL","text":"","code":""},{"path":"j.-molecular-and-cytogenetic.html","id":"jak2","chapter":"J. Molecular and Cytogenetic","heading":"3.16 JAK2","text":"","code":""},{"path":"a.-physiology.html","id":"a.-physiology","chapter":"A. Physiology","heading":"A. Physiology","text":"","code":""},{"path":"a.-physiology.html","id":"coagulation-pathways","chapter":"A. Physiology","heading":"4.1 Coagulation Pathways","text":"","code":""},{"path":"a.-physiology.html","id":"fibrinolytic-pathway","chapter":"A. Physiology","heading":"4.2 Fibrinolytic Pathway","text":"","code":""},{"path":"a.-physiology.html","id":"vasculary-system","chapter":"A. Physiology","heading":"4.3 Vasculary System","text":"","code":""},{"path":"b.-disease-states.html","id":"b.-disease-states","chapter":"B. Disease States","heading":"B. Disease States","text":"","code":""},{"path":"b.-disease-states.html","id":"coagulation-factor-deficiencies","chapter":"B. Disease States","heading":"4.4 Coagulation Factor Deficiencies","text":"","code":""},{"path":"b.-disease-states.html","id":"acquired","chapter":"B. Disease States","heading":"4.4.1 Acquired","text":"","code":""},{"path":"b.-disease-states.html","id":"hereditary","chapter":"B. Disease States","heading":"4.4.2 Hereditary","text":"","code":""},{"path":"b.-disease-states.html","id":"inhibitors","chapter":"B. Disease States","heading":"4.5 Inhibitors","text":"","code":""},{"path":"b.-disease-states.html","id":"fibrinolytic-system","chapter":"B. Disease States","heading":"4.6 Fibrinolytic System","text":"","code":""},{"path":"b.-disease-states.html","id":"hypercoagulable-states","chapter":"B. Disease States","heading":"4.7 Hypercoagulable States","text":"","code":""},{"path":"b.-disease-states.html","id":"dic","chapter":"B. Disease States","heading":"4.8 DIC","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"c.-laboratory-determinations","chapter":"C. Laboratory Determinations","heading":"C. Laboratory Determinations","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"ptinr","chapter":"C. Laboratory Determinations","heading":"4.9 PT/INR","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"aptt","chapter":"C. Laboratory Determinations","heading":"4.10 APTT","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"fibrinogen","chapter":"C. Laboratory Determinations","heading":"4.11 Fibrinogen","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"d-dimer","chapter":"C. Laboratory Determinations","heading":"4.12 D-dimer","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"thrombin-time","chapter":"C. Laboratory Determinations","heading":"4.13 Thrombin Time","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"mixing-studies","chapter":"C. Laboratory Determinations","heading":"4.14 Mixing Studies","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"platelet-function","chapter":"C. Laboratory Determinations","heading":"4.15 Platelet Function","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"inhibitor-assays","chapter":"C. Laboratory Determinations","heading":"4.16 Inhibitor Assays","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"factor-assays","chapter":"C. Laboratory Determinations","heading":"4.17 Factor Assays","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"von-willebrand-assays","chapter":"C. Laboratory Determinations","heading":"4.18 von Willebrand Assays","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"platelet-aggregation","chapter":"C. Laboratory Determinations","heading":"4.19 Platelet Aggregation","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"thromboelastography","chapter":"C. Laboratory Determinations","heading":"4.20 Thromboelastography","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"hypercoagulability-assessment","chapter":"C. Laboratory Determinations","heading":"4.21 Hypercoagulability Assessment","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"assays","chapter":"C. Laboratory Determinations","heading":"4.21.1 Assays","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"molecular","chapter":"C. Laboratory Determinations","heading":"4.21.2 Molecular","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"anti-xa","chapter":"C. Laboratory Determinations","heading":"4.22 Anti-Xa","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"direct-thrombin-inhibitors","chapter":"C. Laboratory Determinations","heading":"4.23 Direct Thrombin Inhibitors","text":"","code":""},{"path":"c.-laboratory-determinations.html","id":"heparin-neutralization","chapter":"C. Laboratory Determinations","heading":"4.24 Heparin Neutralization","text":"","code":""}]
